Neurocognitive Disorders
1
Pipeline Programs
4
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Oregon TherapeuticsSevoflurane
Innovation PharmaceuticalsMeMo web application
Clinical Trials (2)
Total enrollment: 309 patients across 2 trials
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
Start: Aug 2023Est. completion: Mar 2027260 patients
Phase 4Recruiting
Efficacy of the Memory Motivation (MEMO) Web Application Training
Start: May 2017Est. completion: Aug 201949 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 309 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.